It’s been just about a year since we first reported on HairDX, the breakthrough DNA test that looks for a genetic variant found in most bald men. HairDX has certainly helped American hair loss sufferers make better, more informed choices when considering treating their hair loss. As of this month, Japanese men and women will be able to test for their genetic predisposition for hair loss as well.
PharmaGenoma, Inc., is the first company ever to introduce a test of this kind. The company announced its exclusive agreement with Aderans Company Limited of Tokyo. This breakthrough test will be available March 1, 2009 in Japan and sold as a HairDX test collection kit. The kit is listed with Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) as a Class 1 medical device.
The simple and accurate genetic test provides clear information that is easy to understand. HairDX analyzes the likelihood of a man or woman developing Androgenetic Alopecia, the most common type of hair loss.
“Aderans partnership with HairDX will allow people in Japan to learn their risk for hair loss early, so they can choose the best treatment to preserve their hair,” says Katsuji Tokumaru, President of Aderans Co. Ltd. Read more ›
